Author:
Borniger Jeremy C.,Walker II William H.,Gaudier-Diaz Monica M.,Stegman Curtis J.,Zhang Ning,Hollyfield Jennifer L.,Nelson Randy J.,DeVries A. Courtney
Publisher
Springer Science and Business Media LLC
Reference40 articles.
1. Lévi, F., Okyar, A., Dulong, S., Innominato, P. F. & Clairambault, J. Circadian timing in cancer treatments. Annu Rev Pharmacol Toxicol 50, 377–421 (2010).
2. Granda, T. G. et al. Experimental chronotherapy of mouse mammary adenocarcinoma MA13/C with docetaxel and doxorubicin as single agents and in combination. Cancer Res 61, 1996–2001 (2001).
3. Gorbacheva, V. Y. et al. Circadian sensitivity to the chemotherapeutic agent cyclophosphamide depends on the functional status of the CLOCK/BMAL1 transactivation complex. Proc Natl Acad Sci USA 102, 3407–12. (2005).
4. Sothern, R., Halberg, F. & Hrushesky, W. Circadian stage not time-of-day characterizes doxorubicin susceptibility rhythm of mice in continuous light. Annu Rev Chronopharmacol 5, 385 (1988).
5. Levi, F. & Schibler, U. Circadian rhythms: mechanisms and therapeutic implications. Annu Rev Pharmacol Toxicol 47, 593–628 (2007).
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献